Regulation of progesterone receptor signaling by BRCA1 in mammary cancer
暂无分享,去创建一个
E. Rosen | S. Fan | P. Furth | Yongxian Ma | R. Pestell | Richard G. Pestell | Saijun Fan | Pragati Katiyar | Yongxian Ma | Priscilla A. Furth | Eliot M. Rosen | Pragati Katiyar
[1] Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes. , 1991, Molecular and cellular biology.
[2] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[3] Junzhe Xu,et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues , 1995, Nature Genetics.
[4] P. Leder,et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. , 1995, Genes & development.
[5] L. Chodosh,et al. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[7] Simak Ali,et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers , 1998, International journal of cancer.
[8] B. Karlan,et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas , 1999, Nature Genetics.
[9] Thomas Ried,et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.
[10] C. Lange,et al. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. , 1999, Molecular endocrinology.
[11] M. Erdos,et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.
[12] I. Andrulis,et al. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. , 1999, Journal of the National Cancer Institute.
[13] J. Herman,et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.
[14] W. Lee,et al. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Walsh,et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. , 2001, JAMA.
[16] M. Erdos,et al. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity , 2001, Oncogene.
[17] S. Narod. Hormonal Prevention of Hereditary Breast Cancer , 2001, Annals of the New York Academy of Sciences.
[18] M. J. van de Vijver,et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] H. Kawai,et al. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells , 2002, Oncogene.
[20] M. Erdos,et al. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. , 2002, Cancer research.
[21] C. Schairer. Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies , 2002, Breast Cancer Research.
[22] E. Kubista,et al. Brca1 regulates in vitro differentiation of mammary epithelial cells , 2002, Oncogene.
[23] Douglas F Easton,et al. Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.
[24] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[25] J. Isola,et al. Haplo-insufficiency of BRCA1 in sporadic breast cancer. , 2003, Cancer research.
[26] E. Rosen,et al. BRCA1 gene in breast cancer , 2003, Journal of cellular physiology.
[27] K. Offit,et al. Increased Progesterone Receptor Expression in Benign Epithelium of BRCA1-Related Breast Cancers , 2004, Cancer Research.
[28] J. Lydon,et al. Progesterone Receptors in Mammary Gland Development and Tumorigenesis , 2003, Journal of Mammary Gland Biology and Neoplasia.
[29] C. Deng,et al. Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice. , 2005, Oncology reports.
[30] C. Isaacs,et al. BRCA1 in hormonal carcinogenesis: basic and clinical research. , 2005, Endocrine-related cancer.
[31] Minglin Li,et al. Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer , 2005, Oncogene.
[32] E. Rosen,et al. Structural determinants of the BRCA1 : estrogen receptor interaction , 2005, Oncogene.
[33] C. Isaacs,et al. BRCA1 in hormonal carcinogenesis: basic and clinical research. , 2005, Endocrine-related cancer.
[34] E. Rosen,et al. Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1. , 2005, Endocrinology.
[35] C. Y. Wang,et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. , 2005, Journal of the National Cancer Institute.
[36] E. Rosen,et al. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. , 2006, Molecular endocrinology.